comparemela.com

Latest Breaking News On - Monitoring solutions for clinical - Page 1 : comparemela.com

Resverlogix expands apabetalone s Phase IIb trial for Covid-19

Resverlogix has expanded the Phase IIb clinical trial for analysing apabetalone (RVX-208) as a potential oral Covid-19 therapy to Brazil.

Donald mccaffreyCentric services forWorld health organizationMonitoring solutions for clinicalHealth canadaSample servicesOrdinal scaleClinical improvementCentric servicesAlternate site clinical trialsClinical supplyBiological sampleReal time trackingMonitoring solutions

Kintor doses first subject in Phase III Covid-19 therapy trial in China

Kintor Pharmaceutical has dosed the first participant in China in its Phase III trial of proxalutamide to treat Covid-19 outpatients.

Kintor pharmaHongzhou luShanghai public health clinical centerChina national medical products administrationMonitoring solutions for clinicalSample servicesPublic health clinical centerKintor pharmaceuticalThird peopleBeijing ditan hospitalChina japan friendship hospitalFifth peopleHangzhou xixiTong youzhiCost effective preclinical cancer model searchesClinical supply

IGM Biosciences progresses Covid-19 antibody to two clinical trials

IGM Biosciences has announced the progression of its antibody, IGM-6268, into two clinical trials to treat and prevent Covid-19.

South africaSouth africanChris takimotoMonitoring solutions for clinicalKey challengesGlobal clinical trialReal time trackingMonitoring solutions

Direct to patient: the rocky road to remote drug delivery in clinical trials

While an obvious solution to lockdown measures, direct-to-patient remote drug delivery is still an untapped opportunity in clinical trials.

Bhausaheb patilLeo pharmaDale hannaAndrea zobelKarla mackenzieAlexander pytlarzInfuserve americaMonitoring solutions for clinicalHealth insurance portabilityFlash groupTherapeutic goods administrationAdoption trackerTrials arenaClinical trials arenaAccountability actPrivacy rule

BAXE Launches World s First DeFi Ecosystem with Facial Authentication

Australian fintech startup BAXE has partnered with French technology company IDEMIA and Sydney-based startup Haventec to launch the world’s first DeFi (Decentralized finance) ecosystem with facial authentication.

New south walesSdecoret shutterstockMonitoring solutions for clinicalAuthenticate platformIdentity managementEvent conceptionReal time trackingMonitoring solutionsPreference management solution

vimarsana © 2020. All Rights Reserved.